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Purpose: Fibroblast cell proliferation is major reason for recurrence of pterygia. In the present study, we investigated if
small interfering RNA (siRNA)-mediated gene silencing of S phase-kinase-interacting protein 2 (Skp2) can be employed
to inhibit protein 27 kinase inhibition protein 1 (p27kip1) down-regulation in pterygium fibroblast cells (PFC) in vitro and
in vivo.
Methods: A plasmid containing transgenes encoding Skp2 siRNA was used to decreasing the high constitutive levels of
Skp2 protein in PFC and normal fibrboblast cells (NFC) in vitro and in vivo which can lead to consequent degradation of
p27kip1. Cell proliferation and viability were investigated using cell counts, 59-bromodeoxyuridine incorporation (BrdU
assay) and tetrazolium reduction (MTT assay).
Results: Infection of PFC and NFC with Skp2 siRNA resulted in significant inhibition of cell proliferation and metabolic
activity in vitro. Immunoflurescence showed decreased levels of Skp2 and increased levels of p27kip1 in pSkp2 siRNA
infected cells, but not in plasmid and uninfected cells.
Conclusions: Skp2 siRNA inhibited the cell proliferation of PFC in vitro and in vivo.
Pterygium is a common proliferative disorder involving
epithelial hyperplasia and fibrovascular proliferation. In the
advanced stages, pterygium can necessitate complex surgery
for  full  visual  rehabilitation  and  recurrences,  and  ocular
complications are not infrequent [1-3]. Ultraviolet (UV) light
has long been regarded as the etiologic agent of pterygium
[4-6].
The etiology and physiopathology of pterygium have not
been completely defined. However, it is well known from
epidemiologic and histologic studies that the most important
factor in its appearance and development is sunlight exposure.
This  causes  proliferation  of  fibrovascular  tissue  which
invades the cornea from the exposed conjunctiva.
Although  the  pathogenesis  of  pterygium  is  yet
undetermined, tumor-like histologic characteristics, ranging
from  mild  dysplasia  to  carcinoma  in  situ  and  local
invasiveness, have been described by different authors [7-9].
Moreover, pterygium fibroblasts (PFs) exhibit characteristics
of the transformed phenotype [10], microsatellite instability,
and loss of heterozygosity, all reported to be common findings
in neoplastic tissue.
However, the mechanisms in the regulation of lens cell
proliferation are still unclear.
S  phase-kinase-interacting  protein  2  (Skp2)  was
identified as the E3 ubiquitin ligase that targets protein 27
kinase  inhibition  protein  1  (p27kip1)  for  ubiquitination
[11-13].  Skp-cullin-F  (SCF)  complexes  represent  an
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evolutionarily conserved class of E3 enzymes containing four
subunits: Skp1, cullin 1 (Cul1), one of many F box proteins,
and ring box protein 1 (Rbx1) [14]. Skp2, an F box protein, is
required for the ubiquitination and consequent degradation of
p27 both in vivo and in vitro. Skp2 is specifically required for
p27 ubiquitination and that Skp2 is a rate-limiting component
of  the  machinery  that  ubiquitinates  and  degrades
phosphorylated  p27.  Skp2  is  frequently  overexpressed  in
tumor cell lines, and forced expression of Skp2 in quiescent
fibroblasts induces DNA synthesis [15].
We showed that expression of Skp2 can be detected in
rabbit tenon’s fibroblast cells and confirmed that transfection
of Skp2 siRNA can effectively inhibit the proliferation of
rabbit tenon’s fibroblast cells after glaucoma surgery [16].
In this study, we examined the expression of Skp2 in
pterygium fibroblast cells (PFC) and investigated if small
interfering RNA (siRNA)-mediated gene silencing of Skp2
can be employed to inhibit protein 27 kinase inhibition protein
1 (p27kip1) down-regulation in PFC and the effects of down-
regulation of p27kip1 on PFC proliferation.
METHODS
Patient selection: We recruited eight patients with primary
pterygium (age range, 42–66 years; mean, 55.32±2.3 years)
and eight eyes with normal conjunctiva (age range, 45–65
years; mean, 56.25±1.5 years) which were donated. Diagnosis
of pterygium was based on clinical history and evaluation of
signs and symptoms. All patients with pterygium (five men
and three women) had at least a five-year history of a slow-
growing lesion, with a corneal extension of at least 4 mm, as
measured with a caliper, from the limbus to the corneal vertex.
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247Pterygia  morphology  was  clinically  graded  based  on  the
assessment  of  pterygium  translucency:  atrophic  (T1),
intermediate  (T2),  or  fleshy  (T3)  pterygium.  All  pterygia
collected in this study were T3. No subject in the control group
had  any  inflammatory  signs  or  symptoms.  The  research
adhered to the tenets of the Declaration of Helsinki. Written
informed consent was obtained from all the patients before
tissues were collected. This study and all the procedures ere
approved by the Ethics Committee of the University of Harbin
Medical  University.  All  tissue  samples  were  obtained  as
previously described [5]. In summary, at the time of surgery,
tissue was excised from the inner canthus with microforceps.
As a rule, within 1 h of excision, samples were placed in sterile
boxes containing a preservative solution and were transferred
to the cell culture room.
PlasmidSuppressor  (pSuppressor)  containing  Skp2
siRNA and control pSuppressor was purchased from Imgenex
(San  Diego,  CA).  Synthetic  oligonucleotide  primers  was
purchased from Qiagen (Valencia, CA). Skp2 antibody and
the Steptavidin-Alkaline Phosphatase Complex (SABC) kit
were purchased from the Boster Company (Wuhan, China).
Enhanced  chemiluminescence  kit,  p27kip1  antibody,  and
PCNA  antibody  were  purchased  from  Santa  Cruz
Biotechnology,  Inc.  (Santa  Cruz,  CA).  Fluorescein-
conjugated anti-sheep IgG was purchased from Zhongshan
Biotechnology  (Beijing,  China).  Vectashield  mounting
medium was purchased from Vector laboratories (Burlington,
CA). Dulbecco’s modified Eagle’s medium and F12 medium
(DMEM F12) was purchased from Gibco (Burlington, VT).
Streptomycin, penicillin, fetal calf serum and Trizol™ were
purchased from Invitrogen (Carlsbad, CA). Hanks solution
was purchased from Hyclone (Logan, UT). Poly-lysine was
purchased from Sigma (St. louis, MO). Culture plate was
purchased from BD Biosciences (San Jose, CA). Hiperfect
transfection  reagent  was  purchased  from  Qiagen.
Methylthiazolyltetrazolium  (MTT)  was  purchased  from
Sigma. MTT cell proliferation kit was purchased from the
ATCC (Manassas, VA). The Cell Counter was purchased
from Coulter Z1 (Coulter, FL). Metafectene Pro reagent was
purchased from Biontex (Martinstried, Germany).
Equipment: The fluorescence microscope (IX70; Olympus,
Tokyo, Japan), optic microscope (Olympus, Tokyo, Japan),
CO2 incubator (BB16HF: Heal Force, Hong Kong, China),
ultraclean work Table (D8C-010; Heal Force), and incubation
plate (Costar Corporation, Cambridge, MA).
Cell  culture  of  human  pterygium  fibroblasts  (hPF):  For
fibroblast isolation, pterygium and normal conjunctiva tissues
were dissected into three to four tissue fragments (1 mm2).
The planted tissue was attached to the bottom of a six-well
plate  with  a  sterile  coverslip  and  overlaid  with  DMEM
medium.  All  culture  media  were  supplemented  with
streptomycin (50 mg and penicillin 500,000 U/l) . To ensure
Figure 1. Down-regulation of Skp2 protein by siRNA in PFC in vitro by immunoflurescence. Immunoflurescence staining indicated high
constitutive levels of Skp2 protein (arrow indication) in the nucleolus of PFC and NFC transfected with pSuppressor vehicle (A, D) or without
transfection (B, E). Transfection with Skp2 siRNA dramatically decreased the expression of Skp2 protein in PFC cells (C, F). The scale bar
is equal to 40 μm.
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248fibroblast cell proliferation, the media was also supplemented
with fetal calf serum (FCS; 10% of final volume). Cells from
passage 3–5 were used for all experiments. All cells were
grown at 37 °C with 5% CO2 ventilation.
Plasmids and transfection: Vector pSuppressorNeo generates
biologically active siRNAs from the U6promoter. Synthetic
oligonucleotide primers (5’-tcg aGG GAG UGA CAA AGA
CUU UGg agu acu gCA AAG UCU UUG UCA CUC CCU
UUU U-3’ and 5’-cta gAA AAA GGG AGU GAC AAA GAC
UUU Gca gua cuc CAA AGU CUU UGU CAC UCC C-3’)
containing XhoI and XbaI overhangs were annealed and then
were  introduced  into  pSuppressor  Neovector.  Oligo-
nucleotide sequences correspond to a 19-nucleotide sequence
from Skp2 (nucleotides114–133), which is separated by an 8-
nucleotide linker from the reverse complement of the same
19-nucleotide  sequence.  A  transcriptional  termination
(UUUUU) was added to the end of oligonucleotide. We used
circular  control  plasmid,  which  contains  a  scrambled
sequence  as  a  control.  Human  ptergium  fibroblasts  (hPF)
transfected  with  pSuppressor  containing  Skp2  siRNA,
pSuppressor only, and medium served as experimental group,
vehicle control group, and blank control group, respectively.
Transfection was performed in 60 mm plates using 2 μg of
vector in 10 μl of Metafectene Pro reagent. After 48 h of
transfection, cells were treated with G418 for 2 weeks for
positive clone selection. After G418 treatment, we cloned
several stably transfectant cells. Each clone was screened for
expression of Skp2 by western blot analysis.
Immunocytochemistry:  Cells  cultured  on  coverslips  were
fixed  with  4%  paraformaldehyde  for  10  min  at  room
temperature, permeabilized, and blocked with 0.1% Triton
X-100 and 5% goat serum for 30 min. Cells were incubated
with rabbit anti-Vimentin antibody (1:500) at 4 °C overnight,
followed by goat-anti-rabbit IgG (1:500) for 1 h at room
temperature. Then, cells were incubated with strep-avidin-
biotin complex (SABC) at 37 °C for 30 min and colored with
DAB. After coloration with DAB, dehydration, and dimethyl
benzene  treatment,  slides  were  mounted.  Controls  were
stained by omitting the primary antibody.
Cells were incubated with Skp2 monoclonal antibody
(1:500  dilution),  p27kip1  antibody  (1:500  dilution),  PCNA
antibody (1:1,000 dilution) at 4 °C overnight, followed by
secondary  antibody  for  immunoflurescence  staining,
respectively. Controls were stained by omitting the primary
antibody.
Figure 2. Down-regulation of Skp2 protein by siRNA in PFC in vivo by immunoflurescence. Immunoflurescence staining indicated high
constitutive levels of Skp2 protein in the nucleolus of PFC and NFC transfected with pSuppressor vehicle (A, D) or without transfection (B,
E). Transfection with Skp2 siRNA dramatically decreased the expression of Skp2 protein in PFC cells (C, F). The scale bar is equal to 40
μm.
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249(3-(4,5-dimethylthiazolyl-2-)-2,5-
diphenyltetrazoliumbromide, MTT) cell viability assay—
Cell viability was examined by the MTT cell proliferation kit
following the instructions of the manufacturer. The assay is
based on measuring the reduction of yellow tetrazolium to a
purple  for  mazanas  facilitated  by  dehydrogenases  of
metabolically active cells. The intracellular for mazan can be
solubilized  and  quantified  by  spectrophotometric  means.
Quadruple samples of hPFC were grown on 96 well plates and
were infected with 100 mol of either of the two vectors, or
weren’t infected. After 2, 4, 6, 8, and 14 days, wells were
incubated in a medium containing yellow tetrazolium for 20
h.
Cell  proliferation  and  bromodeoxyuridine  (BrdU)
incorporation—Cells (5.0×103) were plated onto a 24-well
multiwell plate (3047, Falcon; Becton Dickinson, Franklin
Lakes, NJ) and allowed to attach for 24 h. The culture medium
was then replaced with fresh medium. Then, trypsinized cells
were counted suing a cell counter (Coulter Z1; Coulter) at 0,
2,  4,  and  6  days.  For  bromodeoxyuridine  (BrdU)
incorporation, cells growing on coverslips were incubated
with 10 μmol/l BrdU for 3 h. The cells were fixed in cold
methanol/acetone  1:1  for  10  min.  In  brief  the  cells  were
sequentially incubated in 1.5 mol/l HCl for 10 min. Then cells
were washed thrice with PBS and incubated with the mouse
anti-BrdU-primary antibody for 1 h. The cells were washed
four times with PBS. The nuclei were simultaneously stained
with 10 mg/ml of 4V, 6-diamidino-2-phenylindole. Cells with
different  BrdU-incorporation  patterns  were  checked  and
counted with a microscope.
Animals:  Male  rabbits  (2–3  kg)  were  supplied  by  the
Experimental Animal Center of Harbin Medical University.
All  animal  care  and  experimental  procedures  were  in
accordance with our institutional guidelines for animal care
and  the  Guide  for  Care  and  Use  of  Laboratory  Animals
published  by  the  US  National  Institutes  of  Health  (NIH
publication no. 85–23, revised 1996).
Developing the pterygium model in rabbits and pSkp2 siRNA
delivery: We transplanted an auricular cartilage fragments
(2×2 mm) obtained from the same rabbit’s ear. The fragment
was grafted onto the upper limbal area of the rabbit’s eye,
positioning it between the conjunctiva and the sclera. The
pterygium  on  the  rabbit  eye  formed  after  the  cartilage
fragment transplantion for six weeks.
A hypothesis concerning the origin of pterygium suggests
that the lachrymal film’s unequal distribution stimulates its
growth. We created an area of irregular distribution of tears
by inserting cartiliage into the rabbits’ scleral-corneal limbus
to evaluate this hypothesis. A slight to moderate inflammatory
reaction was observed during the first days in the surgically
affected  area.  The  reaction  then  disappeared,  leaving  the
cartiliage transplanted in the subconjunctival space visible.
An initial inflammation reaction was observed, followed by
later  formation  of  fibrous  tissue  in  the  injured  area.  Its
macroscopic aspect was similar to that of pterygium. Chronic
inflammation, fibrosis, an increased number of fibroblasts,
and the presence of immune system ploymorphonuclear cells
Figure 3. Skp2 siRNA induced p27kip1 accumulationin in PFC in vitro by immunofluorescence. Immunofluorescence staining indicated the
expression of p27kip1 dramatically increased in PFC and NFC transfection with Skp2 siRNA (C, F) when compared with PFC transfection
with pSuppressor vehicle (A, D) or without transfection (B, E). The scale bar is equal to 40 μm.
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250were  found;  however,  no  elastosis  or  hyalinization  of
subepithelial  connective  tissue  was  observed,  these  being
characteristic signs of pterygium.
Vector (2 µg) in 10 µl of Metafectene was delivered to
the pterygium by subconjunctival injection at the superonasal
quadrant 14 days before the surgery. The pterygium was cut.
The neighboring fibroblast and tenon’s capsule fibroblast was
cut after transfection during the surgery.
BrdU incorporation in vivo: After transfection for 14 days,
0.5  ml  BrdUrd  (10  µmol/l)  was  injected  into  the  tenon’s
capsule fibroblast.
Pathological and histochemistry examinations: The animals
were perfused through the heart with heparin saline followed
by 4% paraformaldehyde after 14 day transfection. Eyes were
fixed overnight, and transferred to a 30% sucrose solution
overnight  (4  °C).  Frozen  sections  (5  μm)  were  cut
longitudinally on a cryostat, thaw mounted onto coated glass
slides,  and  stained  with  hematoxylin  and  eosin  [3],  skp2
antibody, p27kip1 antibody, PCNA antibody, and anti-Brdu-
fluorescein  primary  antibody.  The  procedure  of
histochemistry in vivo was the same as in vitro.
Statistical analysis: Data were analyzed by the two-tailed
Student t-test using Origin ver. 6.0 software (OriginLab Corp.,
Northampton, MA) and a p<0.05 was considered significance.
RESULTS
Downregulation of Skp2 protein by siRNA in hPFC: After 48
h of transfection and 2 weeks of treatment with G418, we
cloned several stably transfectant cells. Immunoflurescence
staining demonstrated high constitutive expression of Skp2
protein in nucleolus of PFC and normal fibroblast cells (NFC)
transfected with pSuppressor vehicle (Figure 1A,D and Figure
2A,D) or without transfection (Figure 1B,E and Figure 2B,E).
Transfection with Skp2 siRNA dramatically decreased the
expression of Skp2 protein in cells of PFC (Figure 1C,F and
Figure 2C,F).
Upregulation of p27kip1 protein by siRNA in hPFC: Skp2 is
required for the ubiquitination and consequent degradation of
p27kip1 [11]. Immunoflurescence staining demonstrated little
expression  of  p27  protein  in  the  PFC  transfected  with
pSuppressor  vehicle  (Figure  3A,D  and  Figure  4A,D)  or
without transfection (Figure 3B,E and Figure 4B,E) in vitro.
Transfection with Skp2 siRNA increased the expression of
p27kip1 protein in cells of PFC and NFC (Figure 3C,F and
Figure 4C,F) in vitro. Upregulation of p27kip1 made it possible
for us to investigate the effect of p27kip1 inhibition on the
proliferation of PFC and NFC.
MTT—After transfection, the number of cells increased
less in Skp2 siRNA transfectant hPFC and hNFC than vehicle
control and blank control groups (Figure 5A,B).
Figure 4. Skp2 siRNA induced p27kip1 accumulationin in PFC in vivo by immunofluorescence. Immunofluorescence staining indicated the
expression of p27kip1 dramatically increased in PFC and NFC transfection with Skp2 siRNA (C, F) when compared with PFC transfection
with pSuppressor vehicle (A, D) or without transfection (B, E). The scale bar is equal to 40 μm.
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251Brdu  incorporation—For  BrdU  incorporation  assay,
cells  growing  on  coverslips  were  incubated  with  BrdU.
Statically analysis (Figure 6A,B) after cell counting showed
that Brdu positive cells in hPF and hNFC transfected with
Skp2 siRNA significantly decreased compared with control
cells (p<0.01 versus vehicle and blank control; Figure 7A,B).
Proliferating cell nuclear antigen (PCNA) protein expression
in PFC after transfection with Skp2 siRNA: PCNA is a marker
that  indicates  the  proliferation  potential  of  cells.
Immunofluorescence  staining  demonstrated  expression  of
PCNA  protein  in  the  hPFC  and  hNFC  transfected  with
pSuppressor  vehicle  (Figure  8A,D  and  Figure  9A,D)  or
without transfection (Figure 8B,E and Figure 9B,E) in vitro.
Transfection with Skp2 siRNA increased the expression of
PCNA protein in cells of hPFC (Figure 8C,F and Figure 9C,F)
in vitro.
Histological  observation  for  inhibition  of  PFC  and  NFC
proliferation: High level of PFC and NFC proliferation can
be  detected  in  vehicle  control  (Figure  10A,D)  and  blank
control (Figure 10B,E). However, PFC and NFC proliferation
decreased in Skp2 siRNA transfectant group (Figure 10C,F).
DISCUSSION
Pterygium  is  a  condition  characterized  by  epithelial
overgrowth of the cornea, usually bilateral, and occupying a
nasal  interpalpebral  location.  It  has  a  characteristic  wing-
shaped  appearance.  The  pterygium  epithelium  that
centripetally invades the cornea display squamous metaplasia
and  goblet  cell  hyperplasia.  There  is  also  an  underlying
breakdown  of  Bowman’s  layer.  A  stromal  overgrowth  of
fibroblasts  and  blood  vessels  is  accompanied  by  an
inflammatory  cell  infiltrate  and  an  abnormal  extracellular
Figure 5. Cell viability assay by MTT. After 6 to 12 days transfection with Skp2 siRNA, cell viability was significantly decreased in cultured
hPFC cells compared with vehicle control and blank control epsecially on the 6th day after transfection. *p<0.01 versus vehicle and blank
control; **p<0.05 versus vehicle and blank control.
Figure 6. Skp2 siRNA inhibited the cell proliferation of PFC in vitro (Brdu). For Brdu incorporation, cells growing on coverslips were incubated
with Brdu. Incorporated Brdu was detected with antibodies as described in the Methods. Statistical analysis after cell counting showed that
Brdu positive cells decreased after hPFC transfection with Skp2 siRNA compared with control cells. **p<0.01 versus vehicle and blank control.
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252matrix  accumulation  composed  of  elastin  and  collagen
[17-22].
Recently,  we  demonstrated  expression  of  matrix
metalloproteinases (MMPs) in resected pterygium specimens
[23,24] and localized these enzymes at the advancing edges
of  the  lesions  [25].  In  addition,  data  suggests  that
proinflammatory cytokines [26] can modify the expression of
these  extracellular  matrix  denaturing  enzymes.  These
investigations imply that MMPs may play a significant role in
tissue  remodeling  and  invasion  and  in  the  dissolution  of
Bowman’s layer associated with pterygia.
Although MMPs may be important effective molecules
in the pathogenesis of pterygia, the roles of cytokines and
growth factors have yet to be established. Several studies have
documented  the  expression  of  cytokines,  such  as  tumor
necrosis factor (TNF), basic fibroblast growth factor (bFGF),
transforming  growth  factor  (TGF),  and  platelet-derived
growth factor (PDGF) in pterygia and cultured pterygium
cells.
In  addition,  the  localization  of  vascular  endothelial
growth  factor  (VEGF)  in  the  pterygium  epithelium  and
vascular  endothelium  and  the  presence  of  intraepithelial
Figure 7. Skp2 siRNA inhibited the cell proliferation of PFC in vivo (Brdu). For Brdu incorporation, ptergium tissue were incubated with
Brdu. Incorporated Brdu was detected with antibodies as described in the Methods. Statistical analysis after cell counting showed that Brdu
positive cells decreased after hPFC transfection with Skp2 siRNA compared with control cells. **p<0.01 versus vehicle and blank control.
Figure 8. Down-regulation of PCNA protein by siRNA in PFC in vitro and in vivo. Immunofluorescence staining indicated the expression of
PCNA decreased in PFC and NFC transfection with Skp2 siRNA (C, F) when compared with hPFC and hNFC transfection with pSuppressor
vehicle (A, D) or without transfection (B, E). The scale bar is equal to 40 μm.
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253capillaries in pterygia suggest a role for angiogenic cytokines
in this disease.
Cellular proliferation is regulated primarily by cell cycle
regulation.  Cell  cycle  progression  is  regulated  by  a
combination  of  positive  and  negative  regulators.  Cyclin-
dependent  kinase  (CDKs)  inhibitors  (CKI)  negatively
regulate progression of the cell cycle by inhibiting the activity
of  cyclin-CDK  complexes.  p27kip1,  a  member  of  the  CKI
family, plays a pivotal role in the control of cell proliferation
[27-29]. The level of p27kip1 is high during the G0 phase but
decreases rapidly upon reentry of the cells into the G1 phase.
Rapid removal of p27kip1 at the G0/G1 transition is required for
effective progression of the cell cycle to S phase [30-32].
According to our study, a low level of p27 kip1 expression was
correlated  with  high  proliferative  and  migratory  capacity,
whereas  nuclear  accumulation  of  the  Cyclin-dependent
kinases inhibition (CKI) was associated with a quiesecnet and
static phenotype. In previous studies, Yoshida et al. suggested
that  the  disappearance  of  p27kip1  was  correlated  with  cell
proliferation in the corneal epithelium after injury [33].
The  level  of  p27kip1  is  regulated  by  Skp2.  Skp2  is
specifically required for p27kip1 ubiquitination and is a rate-
limiting  component  of  the  machinery  that  degrades
phosphorylated p27kip1. Skp2 is constitutively expressed in
normal skin tissue and scar tissue. High expression of Skp2
and  decreased  expression  of  p27kip1  with  fibroblast  from
pathological scar tissue [30]. There is negative correlation
between expression of Skp2 and p27kip1 in fibroblasts from
pathological  scar  tissue.  However,  there  are  no  previous
studies involving the role of Skp2 in hPFC proliferation after
cataract surgery. After 48 h of transfection and 2 weeks of
treatment with G418, transfection with Skp2 siRNA decreased
the  expression  of  Skp2  protein  in  cells  of  hPFC  by
immunoflurescence  staining  and  western  blot.  The  above
indicated  that  transfection  with  Skp2  siRNA  can  inhibit
expression  of  Skp2  in  hPFC  in  vitro  and  vivo.  Then
upregulation  of  p27kip1  of  hPFC  in  vitro  and  in  vivo  was
investigated by immunoflurescence staining and western blot.
After transfection, we confirmed that the number of cells
increased less in Skp2 siRNA transfectant hPFC than vehicle
control and blank control groups by MTT especially on 6th
day. For BrdUrd incorporation assay, high level staining of
BrdU can be detected in hLEC of vehicle control and blank
control,  but  decreased  in  Skp2  siRNA  transfectant  cells.
Furthermore, for the first time, we showed that inhibition of
Skp2 expression by siRNA enhanced p27kip1 protein levels and
prevented hPFC proliferation.
Approaches  to  inhibition  the  hPFC  proliferation  afer
surgery  by  gene  transfer  have  been  reported  by  different
research groups. Nelly et al. [34] showed that Trefoil Factor
1 can inhibit the proliferation of hPFC. Timothy et al. [20]
confirmed that heparin-binding epidermal growth factor–like
growth factor has the potential proliferative function for PFC.
Juan  et  al.  [35]  showed  that  P.  peruviana  fruit  juice  can
inhibition proliferation of PFC.
Figure 9. Down-regulation of PCNA protein by siRNA in PFC in vitro and in vivo. Immunofluorescence staining indicated the expression of
PCNA decreased in PFC and NFC transfection with Skp2 siRNA (C, F) when compared with hPFC and hNFC transfection with pSuppressor
vehicle (A, D) or without transfection (B, E). The scale bar is equal to 40 μm.
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254Finally, the number of cases included in this study is small
and the result maybe has its limitation. In view of the growing
interest in Skp2 and p27kip1 as a target for drug development
in inhibition of hPFC proliferation after surgery, it is our hope
that the data presented here will help to promote going efforts
to decrease the recurrence of pterygium after surgery.
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